Home / 2015 / January

Monthly Archives: January 2015

Alcobra Ltd. Announces Closing of Public Offering of Ordinary Shares and Full Exercise of Over-Allotment Option אלקוברה בע״מ מכריז על סגירת הנפקה של מניות רגילות

After its stock dropped over 80% last year with failed Phase III trial results, Alcobra has raised approximately $27.9 million in a public offering of ordinary shares. The full over allotment option was exercised by the underwriters: 975,000 of the 7.5 million ...

Read More »

Therapix Biosciences and Dekel Pharmaceuticals Sign Binding Term Sheet Outlining Licensing and Royalty Agreement תראפיקס ביוסיינסס בע"מ ודקל פארמסוטיקלס בע"מ חתמו על הסכם לרישוי ותמלוגים

Therapix Biosciences, a biopharma company focused on cannabinoid drugs, has signed a binding term sheet with Dekel Pharmaceuticals for the exclusive worldwide right to develop, manufacture and commercialize combination drug therapies based on Dekel’s technology. The technology is based on the “entourage effect” ...

Read More »

cCAM Biotherapeutics Receives FDA Approval to Initiate Phase 1 Trial for CM-24, a Novel Immune Checkpoint Inhibitor for Cancer Immunotherapy סיקאם ביות'רפיוטיקס בע"מ קיבל את האישור ליזום ניסוי קליני לסרטן

First-in-human Phase 1 trial expected to commence in Q1 2015 MISGAV, Israel–(BUSINESS WIRE)–cCAM Biotherapeutics, a biopharmaceutical company focused on the discovery and development of novel cancer immunotherapies, announced today that it has received approval form the US Food and Drug ...

Read More »

Pluristem Granted Patent for Foundational Cell Harvesting Technology in South Africa פלוריסטם קיבל פטנט בדרום אפריקה לטכנולוגיה לקציר תאים

Patent Covers Methods for Using Vibration to Harvest Large Yields of Viable Cells Grown With Three-Dimensional Technology HAIFA, Israel, Jan. 6, 2015 (GLOBE NEWSWIRE) — Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading developer of placenta-based cell therapy products, announced today that ...

Read More »

Doctors at Rambam Hospital Implant 3-D Printed Jaw in Wounded Syrian Man לסת שהודפסה במדפסת תלת-ממד הושתלה בפצוע סורי בבית החולים רמב״ם

Rambam Medical Center in Haifa has announced the successful implantation of a 3D-printed titanium jaw in a 23-year-old Syrian man after a bullet from his country’s civil war had left his completely destroyed. Ashdod-based AB Dental provided the metal “bone” at ...

Read More »

Can-Fite Announces Upcoming 2015 Clinical Milestones for its Pipeline of Drugs in 4 Indications כן פייט ביופרמה מכריזה על אבני דרך לתרופות ב-4 אינדיקציות

Can-Fite BioPharma Ltd., an advanced clinical stage drug development company, announced its anticipated clinical milestones for 2015. Plans for Q1 include positive results to be released from a Phase II/III psoriasis trial for its lead drug candidate, CF101, and a commercial ...

Read More »

Chiasma Raising Millions Despite Roche Collaboration Debacle כיאזמה גייסה מיליוני דולרים למרות קריסתו של שיתוף הפעולה המתוכנן עם רוש

Jerusalem-based Chiasma has raised $33.8 million of a proposed $56.3 million round, despite cancellation of an approximately $595 million deal with global biotech Roche last summer. New funds were provided by a portfolio of investors including MPM Capital, Abingworth, 7-Med Health Ventures LP, ARCH Venture Partners and F2 and F3 Ventures. Chiasma has shown promise as a ...

Read More »

Integrity Applications, Inc. Announces Completion Of Successful $8.5 Million Equity Financing אינטגריטי אפליקיישנס בע"מ מכריז על השלמת גיוס מוצלח של $8.5 מיליון הון העצמי

Integrity Applications, Inc., developer of the GlucoTrack noninvasive blood glucose monitor, has raised $1,647,450 through a private sale of 1,647.45 ‘units’ of preferred stock and stock options. The company has raised a total of $8.5 million through the sale of 8,500 ‘units’ ...

Read More »

Mazor Robotics Reports Orders for Six Renaissance Systems During the Fourth Quarter of 2014 מזור רובוטיקה מדווחת על הזמנות לשש מערכות רנסנס במהלך הרבעון הרביעי של 2014

Mazor Robotics Ltd., developer of robotic surgical guidance systems, announced that the company received six orders for Renaissance spine surgery systems in fourth quarter 2014. Completion of these agreements did not occur by the end of the year and as a ...

Read More »